Activity of Imatinib Mesylate in Metastatic Anorectal Melanoma: A Case Report

J Gastrointest Cancer. 2012 Sep:43 Suppl 1:S145-7. doi: 10.1007/s12029-011-9340-7.

Authors

Samia Arifi^{1

2}, El Mehdi Tazi³, Omar El Mesbahi⁴, Hassan Errihani³

Affiliations

¹ Department of Medical Oncology, National Institute of Medical Oncology, Rabat, Morocco. [email protected].
² Department of Medical Oncology, Hassan II University Hospital, Route Sidi Harazem, 30000, Fez, Morocco. [email protected].
³ Department of Medical Oncology, National Institute of Medical Oncology, Rabat, Morocco.
⁴ Department of Medical Oncology, Hassan II University Hospital, Route Sidi Harazem, 30000, Fez, Morocco.

PMID: 22045276
DOI: 10.1007/s12029-011-9340-7

No abstract available

Publication types

Case Reports

MeSH terms

Antineoplastic Agents / therapeutic use*
Anus Neoplasms / drug therapy*
Anus Neoplasms / secondary
Humans
Imatinib Mesylate / therapeutic use*
Male
Melanoma / drug therapy*
Melanoma / pathology
Middle Aged
Prognosis
Rectal Neoplasms / drug therapy*
Rectal Neoplasms / secondary
Tomography, X-Ray Computed

Substances

Antineoplastic Agents
Imatinib Mesylate